Brief: Plx Pharma Inc - On April 28, 2020, Co Received Written Notice From Listing Qualifications Department Of Nasdaq
05/05/2020 01:06
May 4 (Reuters) - PLx Pharma Inc PLXP.O :
* PLX PHARMA INC - ON APRIL 28, 2020, CO RECEIVED WRITTEN
NOTICE
FROM LISTING QUALIFICATIONS DEPARTMENT OF NASDAQ
Source text for Eikon: https://bit.ly/3b13mLD
Further company coverage: PLXP.O
((Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice